Studies in recent years have revealed that the PI3K/Akt signaling pathway is abnormally activated in a variety of tumors, including lung cancer, liver cancer, and NPC certainly [16, 17]. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.